Females With Severe or Moderate Hemophilia A or B: an International Multi-center Study

Completed

Conditions studied: Hemophilia A, Hemophilia B

In brief

This is a multi-center, international study designed to collect clinical, genetic and quality of life information on females with hemophilia, an inherited bleeding disorder. The study is designed to determine whether there are problems and issues unique to females with hemophilia.

Key facts

Study ID

NCT00936312

Run by

Weill Medical College of Cornell University

People needed

200

Starts

2008-03-01

Expected to finish

2011-08-01

Last updated by the study team

2012-12-10

Who can join

Age: any. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Females with severe (FVIII<0.01u/ml) or moderate (FVIII 0.01≤0.05 u/ml) hemophilia A
• Females with severe (FIX<0.01u/ml) or moderate (FIX 0.01≤0.05u/ml) hemophilia B
• Willingness to participate in the study.

You may not qualify if…

• Subjects who do not meet the inclusion criteria with respect to gender or hemophilia severity.

Where it is running

• Weill Cornell Medical College — New York, New York, United States
• Princess Margaret Hospital for Children — Perth, Australia
• University Clinic Bonn — Bonn, Germany
• University Clinic Munich — Munich, Germany
• Sheba Medical Center — Tel Litwinsky, Israel
• Instituto G. Gaslini — Genova, Italy
• A. Bianchi Bonomi Hemophilia Center — Milan, Italy
• Nara Medical University — Nara, Japan
• University Hospital Utrecht — Utrecht, Netherlands
• Malmo University Hospital — Malmö, Sweden
• Changhua Christian Hospital — Chunghua City, Changhua, Taiwan

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.